LONDON, March 27, 2019 (GLOBE NEWSWIRE) -- A report from The Business Research Company shows that the global biologics market size is expected to reach around $319 billion by 2021 at an annual growth rate of 9.6%.
The global biologics market report includes the monoclonal antibodies (mAbs) market, therapeutic proteins market and vaccines market. The vaccines market was the smallest segment in the biologics market, accounting for around 15.4% of the market. The vaccines market had the highest annual growth rate of 5.86% during 2013-2017. The rapid growth in the vaccines market can be attributed to the increasing government and non-government initiatives for vaccine R&D activities and prevention of various infectious diseases.
Global Biologics Market Report: https://www.thebusinessresearchcompany.com/report/biologics-global-market-opportunities-and-strategies-to-2021
The top five competitors in the biologics industry made up nearly 59% of the total market share in 2017. The high levels of specialism, expertise, investment and regulatory standing required in the biologics market mean that the market is highly concentrated, with only a small number of drugs approved from a small number of companies. Johnson & Johnson was the largest competitor with 15% of the market, followed by F.Hoffmann-La Roche, and Bristol-Myers Squibb.
Request for A Sample Of The Global Biologics Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=792&type=smp
Biologics Market, Global Opportunities And Strategies To 2021 is one of a series of new reports from The Business Research Company that provide biologics market overviews, analyze and forecast biologics market size and growth for the biologics market, biologics industry segments and geographies, biologics market trends, biologics market drivers, biologics market restraints, biologics industry’s leading competitors’ revenues, profiles and market shares. The Business Research Company has over 300 industry reports, covering over 2400 market segments and 56 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The biologics market reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Email: info@tbrc.info